ATC/DDD Classification (Temporary).
- Published in:
- 2019
- Publication type:
- Chart/Diagram/Graph
Works matching IS 10109609 AND DT 2019 AND VI 33 AND IP 4
Results: 11
1
2
GUIDELINE ON DATA INTEGRITY (October 2019).
- Published in:
- WHO Drug Information, 2019, v. 33, n. 4, p. 773
- Publication type:
- Article
3
PROPOSAL TO DISCONTINUE THE TEST FOR UNDUE TOXICITY (CHAPTER 3.7) IN THE INTERNATIONAL PHARMACOPOEIA (September 2019).
- Published in:
- WHO Drug Information, 2019, v. 33, n. 4, p. 769
- Publication type:
- Article
4
TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIRI DISOPROXILI FUMARAS) Draft proposal for inclusion in The International Pharmacopoeia (September 2019).
- Published in:
- WHO Drug Information, 2019, v. 33, n. 4, p. 757
- Publication type:
- Article
5
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS (DOLUTEGRAVIRI, LAMIVUDINE ET TENOFOVIRI DISOPROXILI FUMARATI COMPRESSI) Draft proposal for inclusion in The International Pharmacopoeia.
- Published in:
- WHO Drug Information, 2019, v. 33, n. 4, p. 745
- Publication type:
- Article
6
DOLUTEGRAVIR TABLETS DOLUTEGRAVIR COMPRESSI Draft proposal for inclusion in The International Pharmacopoeia (September 2019).
- Published in:
- WHO Drug Information, 2019, v. 33, n. 4, p. 738
- Publication type:
- Article
7
DOLUTEGRAVIR SODIUM (DOLUTEGRAVIR NATRICUM) Draft proposal for inclusion in The International Pharmacopoeia (September 2019).
- Published in:
- WHO Drug Information, 2019, v. 33, n. 4, p. 729
- Publication type:
- Article
8
DRAFT MONOGRAPH ON SOFOSBUVIR (SOFOSBUVIRUM) Draft proposal for inclusion in The International Pharmacopoeia (November 2019).
- Published in:
- WHO Drug Information, 2019, v. 33, n. 4, p. 721
- Publication type:
- Article
9
DRAFT PROPOSAL FOR INCLUSION IN THE INTERNATIONAL PHARMACOPOEIA SOFOSBUVIR TABLETS (SOFOSBUVIRI COMPRESSI).
- Published in:
- WHO Drug Information, 2019, v. 33, n. 4, p. 714
- Publication type:
- Article
10
DRAFT MONOGRAPH ON SOFOSBUVIR TABLETS (SOFOSBUVIR COMPRESSI): Draft proposal for inclusion in The International Pharmacopoeia.
- Published in:
- WHO Drug Information, 2019, v. 33, n. 4, p. 713
- Publication type:
- Article
11
ENVIRONMENTAL ASPECTS OF MANUFACTURING FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE.
- Published in:
- WHO Drug Information, 2019, v. 33, n. 4, p. 709
- Publication type:
- Article